High Compliance
- After six weeks of treatment, 80% of patients wear the Narval device seven nights a week
- 81% of patients are still under efficacious treatment after one year
Proven efficacy
- Significant AHI reduction even in severe OSAS patients
- Rapid improvement in sleepiness and quality of life parameters
Improved tolerance
- No pressure on incisors to limit the risk of incisor tilting
- The results on mouth opening and TMJ contact strength tend to demonstrate a better clinical profile in terms of compliance and side effects for Narval traction based MRD1
 |
Benefits for Patients
Discrete, comfortable and effective
- Small, custom-design minimises bulk in the mouth
- Lateral flexibility enables freedom to move the lower jaw
- Absence of contact with incisors minimises dental sensitivity post-wear
- Ability to electively open the mouth
- Patented Optimised Retention of the Mandible (O.R.M.) articulation promotes mouth closing and physiological breathing during sleep
Easy to titrate – highly adjustable (15mm protrusive range)